Editorial
doi: 10.1097/SMJ.0b013e3181bef7bd.
Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy
- PMID: 20016423
- DOI: 10.1097/SMJ.0b013e3181bef7bd
Item in Clipboard
Editorial
Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy
South Med J.
2009 Dec.
No abstract available
Comment on
-
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.South Med J. 2009 Oct;102(10 Suppl):S1-S12. doi: 10.1097/SMJ.0b013e3181ba0d8a. South Med J. 2009. PMID: 19834426 Review.
Similar articles
-
Recent changes in the landscape of combination RAS blockade.Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Expert Rev Cardiovasc Ther. 2009. PMID: 19900020 Review.
-
[Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].Dtsch Med Wochenschr. 2012 Nov;137(48):2498. doi: 10.1055/s-0032-1327303. Epub 2012 Nov 20. Dtsch Med Wochenschr. 2012. PMID: 23168983 German. No abstract available.
-
Renin-angiotensin system blocking drugs.J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):14-33. doi: 10.1177/1074248413501018. Epub 2013 Sep 13. J Cardiovasc Pharmacol Ther. 2014. PMID: 24038019 Review.
-
Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?Med Arh. 2009;63(6):343-9. Med Arh. 2009. PMID: 20380117 Review.
-
Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?Rev Cardiovasc Med. 2006 Spring;7(2):45-54. Rev Cardiovasc Med. 2006. PMID: 16915123 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
